Results 91 to 100 of about 130,177 (190)

Evidence that type 1 plasminogen activator inhibitor binds to the somatomedin B domain of vitronectin.

, 1991
Dietmar Seiffert, David J. Loskutoff
openalex   +1 more source

Salivary Proteomics for Detecting Novel Biomarkers of Periodontitis: A Systematic Review

Journal of Periodontal Research, EarlyView.
Untargeted salivary proteomics identified promising biological molecules consistently over‐ or under‐expressed in periodontitis patients compared to periodontally healthy subjects, but further targeted approaches are required for their validation. ABSTRACT Aim Salivary content is regarded as a powerful diagnostic window for oral and systemic diseases ...
Matteo Corana, Giacomo Baima, Giovanni Iaderosa, Francesco Franco, Jianjian Zhang, Giovanni Nicolao Berta, Federica Romano, Mario Aimetti   +7 more
wiley   +1 more source

Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cells. A potential mechanism in thrombogenesis

, 1991
Orli R. Etingin, D P Hajjar, Katherine A. Hajjar, P C Harpel, Ralph L. Nachman   +4 more
openalex   +1 more source

Endocytosis and lysosomal delivery of tissue plasminogen activator- inhibitor 1 complexes in Hep G2 cells [PDF]

, 1992
David M. Underhill, DA Owensby, PA Morton, Anna L. Schwartz   +3 more
openalex   +1 more source

Coagulation status of immune‐mediated polyarthritis in dogs

Journal of Small Animal Practice, EarlyView.
Objective To describe the coagulation status of dogs with immune‐mediated polyarthritis. Materials and Methods Hospital records at a single referral centre were retrospectively reviewed for dogs diagnosed with immune‐mediated polyarthritis. Cases were classified as hypercoagulable, normocoagulable, hypocoagulable, or hypercoagulable and hypocoagulable ...
L. A. F. Packham, V. Black
wiley   +1 more source

Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory properties.

, 1990
H. J. Ehrlich, Raymond Klein Gebbink, Jaap Keijer, M Linders, Klaus T. Preissner, Hans Pannekoek   +5 more
openalex   +1 more source

Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta. [PDF]

, 1991
Michael Sawdey, David J. Loskutoff
openalex   +1 more source

Localising enzymes to biomolecular condensates increases their accumulation and benefits engineered metabolic pathway performance in Nicotiana benthamiana

Plant Biotechnology Journal, EarlyView.
Summary The establishment of Nicotiana benthamiana as a robust biofactory is complicated by issues such as product toxicity and proteolytic degradation of target proteins/introduced enzymes. Here we investigate whether biomolecular condensates can be used to address these problems. We engineered biomolecular condensates in N.
Anya L. Lindström Battle, Angus W. Barrett, Mark D. Fricker, Lee J. Sweetlove   +3 more
wiley   +1 more source

The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator. [PDF]

, 1990
Raymond R. Schleef, Thomas J. Podor, Eimear Dunne, J Mimuro, David J. Loskutoff   +4 more
openalex   +1 more source

Identification of potential cell surface targets in patient‐derived cultures toward photoimmunotherapy of high‐grade serous ovarian cancer

Photochemistry and Photobiology, EarlyView.
Through mRNA sequencing, proteomics, and flow cytometry, we identified potential cell surface targets toward tumor‐targeted, activatable photoimmunotherapy (taPIT) in advanced high‐grade serous ovarian cancers (HGSOCs) with low EGFR expression. The reliance on EGFR overexpression has been a major limitation of taPIT, which this study seeks to address ...
Sudip Timilsina, Anish Raju Amara, Rafay Abu, Bryan Q. Spring   +3 more
wiley   +1 more source